Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...

辉瑞还面临着专利悬崖的压力，核心产品Eliquis在2024年的销售额预计为73.66亿美元，尽管增长势头良好，但Ibrance将在2025年面临专利到期风险。为了应对这一挑战，辉瑞通过ADC药物及新药研发进行核心产品的生命周期管理，积极布局新增长点 ...

(Reuters) -Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

其中，原公司副总经理刘爱华女士，已超过法定退休年龄，退休时与公司签订了返聘合同，现该返聘合同将于近期到期，且到期后不再续签。刘爱华女士不再担任副总经理职务，后续将不再在公司担任任何职务。

Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment ...

Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...